Status
Terminated
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain hydroxythiohomosildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.
Status
Terminated
Classification
Class I
Report Date
May 22, 2013
Termination Date
May 10, 2018